CHEP Aerospace Solutions, the leading independent provider of outsourced unit load device (ULD) and galley cart services, is delighted to announce that CanTrack™, its energy-harvesting tracking solution for ULDs, has won the inaugural IATA Air Cargo Innovation Award at the World Cargo Symposium (WCS) held in Shanghai.
CanTrack™ is an energy-harvesting self-powered tracking device that is fitted on the container and is integrated with a back-end information system, providing real-time information on the ULD and its cargo. This innovative tracking solution ensures container and cargo damage reduction, greater visibility and increased velocity in the air cargo supply chain, and provides value-added applications for high value and temperature-controlled goods, among other benefits.
CanTrack™ was one of the three finalists shortlisted out of twenty-five initial entries for the final round by a panel of independent industry experts. The finalists presented their projects in front of the full WCS delegation who then cast their votes, being asked to select the innovation that would bring the most benefit to the entire air cargo industry.
CHEP Aerospace Solutions President, Dr. Ludwig Bertsch, said: “We are very proud to have won IATA’s first Air Cargo Innovation Award recognising that our innovation efforts bring benefits not only to our business but to most stakeholders of the air cargo industry as well. We estimate that the asset control feature of our CanTrack™ solution is worth around US$ 5 million annually for CHEP Aerospace Solutions but it may drive benefits of over US$ 200 million a year in the air cargo supply chain by solving various logistics and operational challenges. The dedication and hard work of CHEP’s IT and innovation team during the two-year development of CanTrack™ has been remarkable but I also would like to recognise and thank our technology partner OnAsset Intelligence for their expertise, and our customers, Cargolux for the initial feasibility testing, and Air Canada and Hawaiian Airlines for their participation in the ongoing field trial.”
